You are here: Industry Insights > COVID-19

News List

FDA Authorizes Emergency Use Pfizer Booster Shots for Kids Aged 12-15 drugs
January 03, 2022
The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer's booster shot against COVID-19 for youths aged 12 to 15.
Negative COVID-19 Test May Be Required After Isolation Among Asymptomatic drugs
January 03, 2022
Right now, Americans who have tested positive for COVID-19 but have no symptoms are advised by the U.S. Centers for Disease Control and Prevention to isolate for five days and then wear a mask for another five days when around others.
Israel Will Give Fourth COVID-19 Shot to People Older Than 60, Health Workers drugs
January 03, 2022
Israel will now offer a fourth dose of COVID-19 vaccine to an expanded group of people, as it works to control a wave of the highly contagious omicron variant.
Ascletis expands ritonavir oral tablets production amid Covid-19 surge pharmaceutical-business-review
January 03, 2022
ascletis Pharma is expanding the production of ritonavir oral tablets as well as the oral direct-acting antiviral R&D pipeline to treat SARS-CoV-2 virus amid the recent surge in Covid-19 cases.
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 FirstWordPharma
December 30, 2021
Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders...
Omicron Might Help Shield Against Delta, New Research Suggests drugs
December 30, 2021
Researchers are still trying to figure out what will happen with both the delta and omicron variants of COVID-19 spreading simultaneously.
COVID-19 Can Cause Scarring of Kidneys: Study drugs
December 30, 2021
COVID-19 patients are at risk for serious long-term kidney damage, according to the results of a new investigation.
Texas Children’s Hospital to launch protein sub-unit Covid-19 vaccine pharmaceutical-business-review
December 30, 2021
texas Children's Hospital and Baylor College of Medicine are set to launch Corbevax, a protein sub-unit Covid-19 vaccine in India, with plans to roll out in other underserved countries later.
As Omicron Spreads, Child Hospitalizations Climb 30% in Past Week Drugs
December 29, 2021
Child hospitalizations for COVID-19 jumped 30% this past week as the Omicron variant spread like wildfire throughout the United States.
DCGI grants EUA to Novavax’s Covid-19 vaccine Pharmaceutical-Technology
December 29, 2021
The Drugs Controller General of India (DCGI) has granted emergency use authorization (EUA) to Novavax’s Covid-19 vaccine, NVX-CoV2373, with Matrix-M adjuvant to prevent Covid-19 in adults aged 18 years and older.